4Heil SG, Lievers KJ, Boers GH, et al. Betaine-homocysteine methyltransferase(BHMT) t genomic sequencing and relevance to hyperhomocysteinemia and vascular disease in humans. Mol Genet Metab, 2000, 71:511-519.
5PACIFIC study group. Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heaxt disease. Eur Heart J, 2002, 23: 1509-1515.
6Brattstrom L, Landgren F, Israelsson B, et al. Lowering blood homocysteine with folic acid based supplements: meta-analysls of randomlsed trials. Homocystelne lowering triallsts collaboration. BMJ, 1998, 316:894-898.
7Selhub J, Jacques PF, Wilson PWF, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA, 1993, 270:2693-2698.
8McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol, 1969, 56:111-128.
9Boushey CJ, Beresford SAA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA, 1995, 274:1049-1057.
10Amesen E, Refsum H, Bonaa KH, et al. Serum total homocysteine and coronary heart disease. Int J Epidemiol, 1995, 24 : 704-709,.
9Zhang YX,Cliff WJ,Hong Y,et al.Coronary C reactive protein distribution:its relation to development of atheroseclerosis.Atheroeclerosis,1999,145 (1):375.
10Glasser SP,Selwyn AP,Genz P.Atherosclerosis:risk factors and the vascular endothelim.Am Heart J,1996,131:379.
